GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $129.18 $142.00 Friday, 19th Apr 2024 DXCM stock ended at $130.71. This is 2.67% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.55% from a day low at $129.18 to a day high of $135.06.
90 days $113.05 $142.00
52 weeks $74.75 $142.00

Historical DexCom prices

Date Open High Low Close Volume
2024-03-14 $132.44 $133.00 $128.72 $129.50 2 585 982
2024-03-13 $136.10 $137.46 $131.53 $131.68 2 927 093
2024-03-12 $133.00 $136.73 $130.74 $135.38 3 362 209
2024-03-11 $134.65 $136.40 $133.01 $133.04 2 871 222
2024-03-08 $134.00 $136.25 $132.33 $135.25 3 739 825
2024-03-07 $135.60 $137.93 $132.26 $133.24 5 011 329
2024-03-06 $126.10 $133.94 $124.12 $133.72 9 496 351
2024-03-05 $123.08 $123.91 $120.90 $121.78 3 426 406
2024-03-04 $121.76 $124.30 $120.51 $122.30 3 475 920
2024-03-01 $114.37 $122.23 $113.74 $121.74 4 427 119
2024-02-29 $115.09 $115.56 $114.03 $115.07 3 548 561
2024-02-28 $115.61 $115.68 $113.05 $114.22 2 718 258
2024-02-27 $116.25 $116.42 $114.55 $115.32 2 230 659
2024-02-26 $116.35 $118.19 $115.85 $116.17 2 812 049
2024-02-23 $117.13 $118.49 $116.01 $116.26 6 208 202
2024-02-22 $117.55 $118.00 $115.36 $117.50 3 034 958
2024-02-21 $117.00 $117.94 $115.34 $116.39 2 883 567
2024-02-20 $116.73 $119.10 $116.73 $117.87 3 092 595
2024-02-16 $116.83 $118.81 $116.36 $117.05 3 924 877
2024-02-15 $117.08 $118.51 $116.05 $117.69 3 079 415
2024-02-14 $117.03 $117.70 $114.96 $116.75 3 157 048
2024-02-13 $116.52 $120.24 $116.27 $117.03 3 286 161
2024-02-12 $119.53 $120.47 $117.15 $118.42 4 701 300
2024-02-09 $123.00 $124.99 $120.29 $120.47 5 602 563
2024-02-08 $127.20 $127.37 $125.21 $127.05 4 099 214
Click to get the best stock tips daily for free!

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i... DXCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT